Page 712«..1020..711712713714..720730..»

Randolph veterinarian uses new stem cell therapy on ailing pets – Video

By NEVAGiles23

When it comes to improving the lives of the animals he treats, veterinarian Brian Voynick isn't afraid to try something new. He's been doing acupuncture on dogs for some 15 years. So when Voynick first heard about stem cell therapy for small animals like cats and dogs four years ago at a conference on holistic veterinary medicine, he was intrigued.

Go here to see the original:
Randolph veterinarian uses new stem cell therapy on ailing pets - Video

To Read More: Randolph veterinarian uses new stem cell therapy on ailing pets – Video
categoriaUncategorized commentoComments Off on Randolph veterinarian uses new stem cell therapy on ailing pets – Video | dataOctober 13th, 2011
Read All

Elaine Fuchs Part 1: Introduction to Stem Cells English Subtitle

By Dr. Matthew Watson

http://www.ibioseminars.org During embryogenesis, a single fertilized oocyte gives rise to a multicellular organism whose cells and tissues have adopted differentiated characteristics or fates to perform the specified functions of each organ of the body. As embryos develop, cells that have acquired their particular fate proliferate, enabling tissues and organs to grow

Follow this link:
Elaine Fuchs Part 1: Introduction to Stem Cells English Subtitle

To Read More: Elaine Fuchs Part 1: Introduction to Stem Cells English Subtitle
categoriaSkin Stem Cells commentoComments Off on Elaine Fuchs Part 1: Introduction to Stem Cells English Subtitle | dataOctober 12th, 2011
Read All

Harvesting stem cells from horse bone marrow at UT

By Dr. Matthew Watson

Staff at the University of Tennessee Veterinary Medical Center demonstrate how they harvest allogenic stem cells from horse bone marrow.

Follow this link:
Harvesting stem cells from horse bone marrow at UT

To Read More: Harvesting stem cells from horse bone marrow at UT
categoriaBone Marrow Stem Cells commentoComments Off on Harvesting stem cells from horse bone marrow at UT | dataOctober 12th, 2011
Read All

Chocolate compounds fight high cholesterol

By Dr. Matthew Watson

Chocolate has received a lot of attention for being a treasure trove of nutritional goodness. Polyphenols in cacao beans are linked to promoting heart, brain, and liver health, which has sparked renewed interest in chocolate as a medicinal food. And a new study adds to the growing list of benefits, showing that chocolate polyphenols also help to lower bad cholesterol.

Published in the journal Diabetic Medicine, the study tested the effects of polyphenol-rich chocolate in a group of 12 volunteers with type-2 diabetes. After 16 weeks, the researchers from Hull University in the U.K. discovered that the polyphenols helped lower participants' bad cholesterol levels while raising good cholesterol levels.

"Chocolate with a high cocoa content should be included in the diet of individuals with type-2 diabetes as part of a sensible, balanced approach to diet and lifestyle," said professor Steve Akin, author of the study. Read more...

Immunice for Immune Support

Source:
http://feeds.feedburner.com/integratedmedicine

To Read More: Chocolate compounds fight high cholesterol
categoriaIntegrative Medicine commentoComments Off on Chocolate compounds fight high cholesterol | dataOctober 9th, 2011
Read All

International Stem Cell Corp. Chairman Kenneth Aldrich Comments on Recent TIME Article “A Stem Cell First: Using the ‘Dolly’ Method on Human Cells”

By Dr. Matthew Watson

“Since we at International Stem Cell Corporation (trading symbol: ISCO.OB) are licensees of some of the key intellectual property necessary to use SCNT in therapeutic products, we were delighted to read about this new discovery.  However, what disappointed us somewhat was the failure of most news reports to mention that a technology already exists that solves the same ethical problems and has the potential also to solve many of the problems of immune rejection that worry scientists who are working with cells obtained from fertilized embryos.
That technology is called "Parthenogenesis" and results in a "cell line" that can provide an essentially unlimited supply of human cells for a wide range of therapeutic purposes, yet does not involve the destruction of any fertilized embryo and results in cells that can be matched to large groups of people who may not even know the patient, much like the way blood from donors can be stored and used by accident victims as needed. Unlike the SCNT cells, parthenogenetic cells require no genetic manipulation or insertion of foreign DNA.
Our scientists at ISCO created and patented the process for making such human parthenogenetic stem cell lines and have already successfully made liver cells, cornea cells, retina cells and nerve cells from those cell lines.  Each of these applications is being studied as a possible future source of transplanted cells to treat diseases such as Parkinson's, Liver Disease, Macular Degeneration, and others. 
To learn more about parthenogenesis, visit our website at http://www.internationalstemcell.com or click on ISCO.OB at any financial web site for information about our company.”
Kenneth C. Aldrich
Chairman
International Stem Cell Corporation
TIME Article – A Stem Cell First: Using the 'Dolly' Method on Human Cells
About International Stem Cell Corporation
International Stem Cell Corporation is focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. ISCO's core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs). hpSCs avoid ethical issues associated with the use or destruction of viable human embryos. ISCO scientists have created the first parthenogenic, homozygous stem cell line that can be a source of therapeutic cells for hundreds of millions of individuals of differing genders, ages and racial background with minimal immune rejection after transplantation. hpSCs offer the potential to create the first true stem cell bank, UniStemCell™. ISCO also produces and markets specialized cells and growth media for therapeutic research worldwide through its subsidiary Lifeline Cell Technology, and cell-based skin care products through its subsidiary Lifeline Skin Care. More information is available at http://www.internationalstemcell.com.
To subscribe to receive ongoing corporate communications, please click on the following link:http://www.b2i.us/irpass.asp?BzID=1468&to=ea&s=0 .
Forward-looking Statements
Statements pertaining to anticipated developments, and other opportunities for the company and its subsidiaries, along with other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements. Any statements that are not historical fact (including, but not limited to statements that contain words such as "will," "believes," "plans," "anticipates," "expects," "estimates,") should also be considered to be forward-looking statements. Forward-looking statements involve risks and uncertainties, including, without limitation, risks inherent in the development and/or commercialization of potential products and the management of collaborations, regulatory approvals, need and ability to obtain future capital, application of capital resources among competing uses, and maintenance of intellectual property rights. Actual results may differ materially from the results anticipated in these forward-looking statements and as such should be evaluated together with the many uncertainties that affect the company's business, particularly those mentioned in the cautionary statements found in the company's Securities and Exchange Commission filings. The company disclaims any intent or obligation to update forward-looking statements.

Source:
http://intlstemcell.blogspot.com/feeds/posts/default?alt=rss

To Read More: International Stem Cell Corp. Chairman Kenneth Aldrich Comments on Recent TIME Article “A Stem Cell First: Using the ‘Dolly’ Method on Human Cells”
categoriaStem Cell Therapy commentoComments Off on International Stem Cell Corp. Chairman Kenneth Aldrich Comments on Recent TIME Article “A Stem Cell First: Using the ‘Dolly’ Method on Human Cells” | dataOctober 9th, 2011
Read All

International Stem Cell Names Dr. Andrey Semechkin as Co-Chairman and Kurt May as President and Chief Operating Officer

By Dr. Matthew Watson

International Stem Cell Corporation (OTCBB:ISCO) today announced that its Board of Directors designated Dr. Andrey Semechkin, the Company's Chief Executive Officer, as a Co-Chairman with the Company's founder, Kenneth Aldrich, and also named Kurt May as President and Chief Operating Officer, effective immediately. Mr. May is currently Senior Vice President and this represents both a promotion and the delegation of additional duties and responsibilities consistent with his increasingly important role in the future of ISCO.
Dr. Semechkin commented, "Kurt May is an extremely capable executive who has managed both a multi-billion dollar public company and a successful life sciences startup company. His willingness to assume operational responsibilities for ISCO will allow me, as CEO, to focus more intently on scientific and strategic initiatives that are central to developing ISCO into a major force in the world of stem cell therapy. Working together with the fine team of executives and scientists already within ISCO, I have high hopes and confidence we can reach that goal."
Prior to joining ISCO, Mr. May was a senior executive with GTE Corporation and with PriceSmart, Inc., and the founder and CEO of a privately owned biotech company, Psynomics, based on medical technology derived from the University of California, San Diego. Mr. May served as a faculty member and Assistant Dean of UCSD's Rady School of Management from 2005 to 2009.
During his tenure as PriceSmart's Chief Operating Officer, Mr. May led the company from startup to growth over three years that included establishing 22 stores in 11 countries, reaching annual revenues of more than $500 million, achieving profitability, and expanding staff from 356 to more than 4,200.

"In addition to its therapeutic programs, ISCO is dedicated to building its revenue-generating subsidiaries to high levels of profitability. We view Mr. May's commercial and entrepreneurial skills as an essential part of our business plan for success," said Kenneth Aldrich, Co-Founder and Co-Chairman of ISCO.
About International Stem Cell Corporation
International Stem Cell Corporation is focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. ISCO's core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs). hpSCs avoid ethical issues associated with the use or destruction of viable human embryos. ISCO scientists have created the first parthenogenic, homozygous stem cell line that can be a source of therapeutic cells for hundreds of millions of individuals of differing genders, ages and racial background with minimal immune rejection after transplantation. hpSCs offer the potential to create the first true stem cell bank, UniStemCell™. ISCO also produces and markets specialized cells and growth media for therapeutic research worldwide through its subsidiary Lifeline Cell Technology, and cell-based skin care products through its subsidiary Lifeline Skin Care. More information is available at http://www.internationalstemcell.com.
To subscribe to receive ongoing corporate communications, please click on the following link:http://www.b2i.us/irpass.asp?BzID=1468&to=ea&s=0.
Forward-looking Statements
Statements pertaining to anticipated developments, and other opportunities for the company and its subsidiaries, along with other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements. Any statements that are not historical fact (including, but not limited to statements that contain words such as "will," "believes," "plans," "anticipates," "expects," "estimates,") should also be considered to be forward-looking statements. Forward-looking statements involve risks and uncertainties, including, without limitation, risks inherent in the development and/or commercialization of potential products and the management of collaborations, regulatory approvals, need and ability to obtain future capital, application of capital resources among competing uses, and maintenance of intellectual property rights. Actual results may differ materially from the results anticipated in these forward-looking statements and as such should be evaluated together with the many uncertainties that affect the company's business, particularly those mentioned in the cautionary statements found in the company's Securities and Exchange Commission filings. The company disclaims any intent or obligation to update forward-looking statements.
http://cts.businesswire.com/ct/CT?id=bwnews&sty=20111006005285r1&sid=14230&distro=ftp
International Stem Cell Corporation

Kenneth C. Aldrich, Co-Chairman
760-940-6383
kaldrich@intlstemcell.com
or
Lippert/Heilshorn & Associates
Don Markley, 310-691-7100
dmarkley@lhai.com

Source:
http://intlstemcell.blogspot.com/feeds/posts/default?alt=rss

To Read More: International Stem Cell Names Dr. Andrey Semechkin as Co-Chairman and Kurt May as President and Chief Operating Officer
categoriaStem Cell Therapy commentoComments Off on International Stem Cell Names Dr. Andrey Semechkin as Co-Chairman and Kurt May as President and Chief Operating Officer | dataOctober 9th, 2011
Read All

Stem Cells: Hope, Hype and Progress – Session 1b

By daniellenierenberg

Session 1b: Cell Transplantation for Spinal Cord Repair Professor Alan Mackay-Sim presents at the "Stem Cells: Hope, Hype and Progress" workshop held in Brisbane in July 2011

Follow this link:
Stem Cells: Hope, Hype and Progress - Session 1b

To Read More: Stem Cells: Hope, Hype and Progress – Session 1b
categoriaSpinal Cord Stem Cells commentoComments Off on Stem Cells: Hope, Hype and Progress – Session 1b | dataOctober 8th, 2011
Read All

Mesenchymal stem cells and marrow stromal cells—2nd—

By Dr. Matthew Watson

Marrow stromal cells The existence of nonhematopoietic cells in bone marrow was first suggested by Cohnheim about 130 years ago [16]. To date, marrow stromal cells have been shown to differentiate into osteoblasts [17], chondrocytes [18], skeletal myocytes, adipocytes, and cardiomyocytes [19] in vitro, and thus are a useful cell source for regenerative medicine [20, 21]. Recent studies suggest that bone marrow stromal cells can also differentiate into a neuronal lineage [14], and murine bone marrow derived multipotent adult progenitor cell differentiate into dopaminergic neuronal cells [22].

Excerpt from:
Mesenchymal stem cells and marrow stromal cells---2nd---

To Read More: Mesenchymal stem cells and marrow stromal cells—2nd—
categoriaBone Marrow Stem Cells commentoComments Off on Mesenchymal stem cells and marrow stromal cells—2nd— | dataOctober 8th, 2011
Read All

Dr Nathan Newman Stem Cell Face Lift on Entertainment Tonight

By daniellenierenberg

http://www.SmootherSkin.info Dr Nathan Newman on Entertainment Tonight demonstrating his Stem Cell Lift. Dr Newman has developed a Stem Cell Facial Serum for his patients to use after the Stem Cell Lift. You can also use this anti-aging stem cell skin care instead of the stem cell facelift.

Originally posted here:
Dr Nathan Newman Stem Cell Face Lift on Entertainment Tonight

To Read More: Dr Nathan Newman Stem Cell Face Lift on Entertainment Tonight
categoriaSkin Stem Cells commentoComments Off on Dr Nathan Newman Stem Cell Face Lift on Entertainment Tonight | dataOctober 8th, 2011
Read All

UK’s first approved adult stem cell bank Oristem® explained

By JoanneRUSSELL25

Athol Haas CEO of Pharmacells™ explains the technology behing UK's first approved adult stem cell banking product and why you should consider banking your stem cells now rather than later.

Continued here:
UK's first approved adult stem cell bank Oristem® explained

To Read More: UK’s first approved adult stem cell bank Oristem® explained
categoriaSpinal Cord Stem Cells commentoComments Off on UK’s first approved adult stem cell bank Oristem® explained | dataOctober 6th, 2011
Read All

Health and Home Stem-1

By Sykes24Tracey

Canadians are traveling to China and India for stem cell injections and reporting incredible improvements. We'll meet a young BC man who broke his back a year ago. He was told he'd never move from the chest down but refused to accept that.

Continue reading here:
Health and Home Stem-1

To Read More: Health and Home Stem-1
categoriaSpinal Cord Stem Cells commentoComments Off on Health and Home Stem-1 | dataOctober 6th, 2011
Read All

Webinar 1, Stem cell therapy basics, what is available today?

By LizaAVILA

This video, is a webinar presentation with educational purposes, talks about the basics of stem cells and stem cells treatments. Explains: what is a stem cell?

More:
Webinar 1, Stem cell therapy basics, what is available today?

To Read More: Webinar 1, Stem cell therapy basics, what is available today?
categoriaBone Marrow Stem Cells commentoComments Off on Webinar 1, Stem cell therapy basics, what is available today? | dataOctober 6th, 2011
Read All

Stem Cell Banking: The Perspective of an iPS Donor Family

By JoanneRUSSELL25

"Your twin daughters have an extremely rare, fatal disease called Niemann Pick Type C and there's nothing you can do for them". Those were the devastating words that Chris Hempel and her husband first heard in 2007. Rather than just give in to this fate, the Hempels are proactively engaging researchers to try to save Addi and Cassi's lives

Original post:
Stem Cell Banking: The Perspective of an iPS Donor Family

To Read More: Stem Cell Banking: The Perspective of an iPS Donor Family
categoriaSkin Stem Cells commentoComments Off on Stem Cell Banking: The Perspective of an iPS Donor Family | dataOctober 6th, 2011
Read All

Glazer’s Edge: Peyton’s Stem Cells

By NEVAGiles23

Jay Glazer has the latest on Peyton Manning's neck injury.

Read more:
Glazer's Edge: Peyton's Stem Cells

To Read More: Glazer’s Edge: Peyton’s Stem Cells
categoriaUncategorized commentoComments Off on Glazer’s Edge: Peyton’s Stem Cells | dataOctober 6th, 2011
Read All

Spinal Patient Receives Stem Cells in First Experimental Treatment

By JoanneRUSSELL25

The US News and World Report reports that a partially paralyzed spinal cord injury patient was injected with stem cells on Friday in the first human embryonic stem cell experimental treatment performed on a human. Geron, the company that developed the cells and the first to hold an FDA license to use the cells in treatment, says the stem cells came from human embryos left over from fertility treatments and were converted into nerve cells before being injected into the damaged area of the spinal cord

Read the original:
Spinal Patient Receives Stem Cells in First Experimental Treatment

To Read More: Spinal Patient Receives Stem Cells in First Experimental Treatment
categoriaSpinal Cord Stem Cells commentoComments Off on Spinal Patient Receives Stem Cells in First Experimental Treatment | dataOctober 6th, 2011
Read All

Noah Stem Cell Transplant Day 3

By Dr. Matthew Watson

This is the 3rd day after Noah got a stem cell transplant for a back injury. Pause for Paws Rescue, San Antonio, TX

See the original post here:
Noah Stem Cell Transplant Day 3

To Read More: Noah Stem Cell Transplant Day 3
categoriaSpinal Cord Stem Cells commentoComments Off on Noah Stem Cell Transplant Day 3 | dataOctober 6th, 2011
Read All

Stem Cells extracted from bone marrow

By Dr. Matthew Watson

Details adult stem cells being extracted from human bone marrow via a syringe. Animation by Laura Lynn Gonzalez lauralynngonzalez.com

Excerpt from:
Stem Cells extracted from bone marrow

To Read More: Stem Cells extracted from bone marrow
categoriaBone Marrow Stem Cells commentoComments Off on Stem Cells extracted from bone marrow | dataOctober 6th, 2011
Read All

Ellis Martin Report with International Stem Cell Corp

By raymumme

In this interview, Ellis Martin speaks with Kenneth Aldrich of International Stem Cell Corporation (ISCO.OB) about continuing research and revenue generated by Lifeline Stem Cell technology, including Lifeline Skin Care Creams. Is International Stem Cell working on a cure for melanoma or cancer

Read the original post:
Ellis Martin Report with International Stem Cell Corp

To Read More: Ellis Martin Report with International Stem Cell Corp
categoriaSkin Stem Cells commentoComments Off on Ellis Martin Report with International Stem Cell Corp | dataOctober 6th, 2011
Read All

Repair Your Joint Injuries With Stem Cell Therapy | Los Angeles | Beverly Hills | Hollywood

By daniellenierenberg

metromd.net Stem Cell Therapy for Repairing Joint Injuries | Stem Cell Therapy is effective in many orthopedic applications. Restore function and relieve pain from torn ligaments, tendons and damaged cartilage.

Link:
Repair Your Joint Injuries With Stem Cell Therapy | Los Angeles | Beverly Hills | Hollywood

To Read More: Repair Your Joint Injuries With Stem Cell Therapy | Los Angeles | Beverly Hills | Hollywood
categoriaUncategorized commentoComments Off on Repair Your Joint Injuries With Stem Cell Therapy | Los Angeles | Beverly Hills | Hollywood | dataOctober 6th, 2011
Read All

Roman Reed: What all patient advocates at the World Stem Cell Summit should know

By daniellenierenberg

Roman Reed spoke with CIRM at the World Stem Cell Summit about what he thinks patients advocates should know about stem cell research.

Read the original here:
Roman Reed: What all patient advocates at the World Stem Cell Summit should know

To Read More: Roman Reed: What all patient advocates at the World Stem Cell Summit should know
categoriaSpinal Cord Stem Cells commentoComments Off on Roman Reed: What all patient advocates at the World Stem Cell Summit should know | dataOctober 6th, 2011
Read All

Page 712«..1020..711712713714..720730..»


Copyright :: 2025